BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Teachers College, Columbia University//NONSGML//EN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:GMT
BEGIN:STANDARD
DTSTART:20130225T000000Z
TZOFFSETFROM:-0400
TZOFFSETTO:-0400
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
TRANSP:OPAQUE
XMICROSOFT-CDO-IMPORTANCE:1
CLASS:PUBLIC
SEQUENCE:0
UID:calendar@tc.columbia.edu
DTSTART;TZID=GMT:20130225T150000
DTEND;TZID=GMT:20130225T164500
DTSTAMP;VALUE=DATE:20130225
SUMMARY:Neuroscience Lecture Series: Robert E. Burke, M.D. | Reconstruction of the Adult Nigrostriatal Dopaminergic Pathway: A New Approach to the treatment of Parkinson's Disease
DESCRIPTION: Parkinson&#8217;s disease (PD) is a chronic, progressive neurologic disorder that causes impairment of movement.&nbsp; Available treatments for PD offer relief of symptoms, but none are able to restore the neural structures that have degenerated.&nbsp; Neuroscientists have long believed that surviving mature neurons in the brain are incapable of new axon growth.&nbsp; However, there is emerging evidence that this belief is not true, that surviving neurons may be induced to re-grow axons by re-activation of molecular processes that are active during normal brain development.&nbsp; Our research explores gene therapy approaches to re-activation of these axon growth processes.&nbsp; The motor impairments in PD are due to the degeneration of dopaminergic neurons and their axons.&nbsp; We have investigated the ability of two genes that are active in axon growth during development: a kinase Akt and one of its downstream targets, the GTPase hRheb. We have found that both Akt and hRheb, when expressed in dopamine neurons by use of a viral vector, induce robust new axon growth and achieve partial restoration of function.&nbsp; At the time of first diagnosis of PD, 70% of the neurons of the substantia nigra still survive.&nbsp; If they can be induced to re-grow their axons, and re-establish their ability to release dopamine, it may be possible to offer substantial neurorestoration with clinical benefit.&nbsp; The promise of this approach is that this benefit will be achieved by endogenous dopamine neurons, in their normal locations, with intact connections and with normal regulatory mechanisms in place. &nbsp; This event is part of the Neuroscience &amp; Education program's Spring 2013 Neuroscience Lecture Series. Some of the most accomplished investigators in neuroscience from top universities in the NYC area will be presenting new developments in their leading-edge research on the frontiers of neuroscience. Click Here for a full list of speakers and topics 
LOCATION:Cowin Center, 147 HM
URL:http://www.tc.edu/bbs/seminars
END:VEVENT
END:VCALENDAR